Last updated on 27 May 2021
Owner Info
Cygnal Therapeutics, Inc.
325 Vassar Street, Suite 2B
Cambridge MA 02139, UNITED STATES OF AMERICA
Serial Number
2090112 filed on 13 Apr 2020
Correspondent
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
600 Atlantic Avenue,
Boston MA 02210-2206,
UNITED STATES OF AMERICA
2090112
13 Apr 2020
13 Apr 2030
WORD
11 Oct 2019
US
Status Date | Action Taken |
---|---|
27th May 2021 | Amendment to Amend Owner Requested |
18th Nov 2020 | International Registration in Australia Protected correspondence sent |
17th Nov 2020 | IP Right Registration Published |
17th Nov 2020 | Status change to Registered/Protected |
11th Sept 2020 | Application Accepted correspondence sent |
10th Sept 2020 | IP Right has been Examined |
10th Sept 2020 | IP Right Acceptance Published |
10th Sept 2020 | Status change to Accepted |
21st May 2020 | Awaiting examination |
21st May 2020 | Examination expedited |